Global Interleukin 1 (IL1) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Interleukin 1 (IL1) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Interleukin 1 (IL1) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Interleukin 1 (IL1) by Country/Region, 2017, 2022 & 2028

2.2 Interleukin 1 (IL1) Segment by Type

2.2.1 APX-002

2.2.2 Canakinumab

2.2.3 Diacerein CR

2.2.4 IR-1000

2.2.5 Others

2.3 Interleukin 1 (IL1) Sales by Type

2.3.1 Global Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)

2.3.2 Global Interleukin 1 (IL1) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Interleukin 1 (IL1) Sale Price by Type (2017-2022)

2.4 Interleukin 1 (IL1) Segment by Application

2.4.1 Esophageal Cancer

2.4.2 Fallopian Tube Cancer

2.4.3 Bladder Cancer

2.4.4 Bechcer Disease

2.4.5 Others

2.5 Interleukin 1 (IL1) Sales by Application

2.5.1 Global Interleukin 1 (IL1) Sale Market Share by Application (2017-2022)

2.5.2 Global Interleukin 1 (IL1) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Interleukin 1 (IL1) Sale Price by Application (2017-2022)

3 Global Interleukin 1 (IL1) by Company

3.1 Global Interleukin 1 (IL1) Breakdown Data by Company

3.1.1 Global Interleukin 1 (IL1) Annual Sales by Company (2020-2022)

3.1.2 Global Interleukin 1 (IL1) Sales Market Share by Company (2020-2022)

3.2 Global Interleukin 1 (IL1) Annual Revenue by Company (2020-2022)

3.2.1 Global Interleukin 1 (IL1) Revenue by Company (2020-2022)

3.2.2 Global Interleukin 1 (IL1) Revenue Market Share by Company (2020-2022)

3.3 Global Interleukin 1 (IL1) Sale Price by Company

3.4 Key Manufacturers Interleukin 1 (IL1) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Interleukin 1 (IL1) Product Location Distribution

3.4.2 Players Interleukin 1 (IL1) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Interleukin 1 (IL1) by Geographic Region

4.1 World Historic Interleukin 1 (IL1) Market Size by Geographic Region (2017-2022)

4.1.1 Global Interleukin 1 (IL1) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Interleukin 1 (IL1) Annual Revenue by Geographic Region

4.2 World Historic Interleukin 1 (IL1) Market Size by Country/Region (2017-2022)

4.2.1 Global Interleukin 1 (IL1) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Interleukin 1 (IL1) Annual Revenue by Country/Region

4.3 Americas Interleukin 1 (IL1) Sales Growth

4.4 APAC Interleukin 1 (IL1) Sales Growth

4.5 Europe Interleukin 1 (IL1) Sales Growth

4.6 Middle East & Africa Interleukin 1 (IL1) Sales Growth

5 Americas

5.1 Americas Interleukin 1 (IL1) Sales by Country

5.1.1 Americas Interleukin 1 (IL1) Sales by Country (2017-2022)

5.1.2 Americas Interleukin 1 (IL1) Revenue by Country (2017-2022)

5.2 Americas Interleukin 1 (IL1) Sales by Type

5.3 Americas Interleukin 1 (IL1) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Interleukin 1 (IL1) Sales by Region

6.1.1 APAC Interleukin 1 (IL1) Sales by Region (2017-2022)

6.1.2 APAC Interleukin 1 (IL1) Revenue by Region (2017-2022)

6.2 APAC Interleukin 1 (IL1) Sales by Type

6.3 APAC Interleukin 1 (IL1) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Interleukin 1 (IL1) by Country

7.1.1 Europe Interleukin 1 (IL1) Sales by Country (2017-2022)

7.1.2 Europe Interleukin 1 (IL1) Revenue by Country (2017-2022)

7.2 Europe Interleukin 1 (IL1) Sales by Type

7.3 Europe Interleukin 1 (IL1) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Interleukin 1 (IL1) by Country

8.1.1 Middle East & Africa Interleukin 1 (IL1) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Interleukin 1 (IL1) Revenue by Country (2017-2022)

8.2 Middle East & Africa Interleukin 1 (IL1) Sales by Type

8.3 Middle East & Africa Interleukin 1 (IL1) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Interleukin 1 (IL1)

10.3 Manufacturing Process Analysis of Interleukin 1 (IL1)

10.4 Industry Chain Structure of Interleukin 1 (IL1)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Interleukin 1 (IL1) Distributors

11.3 Interleukin 1 (IL1) Customer

12 World Forecast Review for Interleukin 1 (IL1) by Geographic Region

12.1 Global Interleukin 1 (IL1) Market Size Forecast by Region

12.1.1 Global Interleukin 1 (IL1) Forecast by Region (2023-2028)

12.1.2 Global Interleukin 1 (IL1) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Interleukin 1 (IL1) Forecast by Type

12.7 Global Interleukin 1 (IL1) Forecast by Application

13 Key Players Analysis

13.1 Optimum Therapeutics LLC

13.1.1 Optimum Therapeutics LLC Company Information

13.1.2 Optimum Therapeutics LLC Interleukin 1 (IL1) Product Offered

13.1.3 Optimum Therapeutics LLC Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Optimum Therapeutics LLC Main Business Overview

13.1.5 Optimum Therapeutics LLC Latest Developments

13.2 Orphit SAS

13.2.1 Orphit SAS Company Information

13.2.2 Orphit SAS Interleukin 1 (IL1) Product Offered

13.2.3 Orphit SAS Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Orphit SAS Main Business Overview

13.2.5 Orphit SAS Latest Developments

13.3 Peptinov SAS

13.3.1 Peptinov SAS Company Information

13.3.2 Peptinov SAS Interleukin 1 (IL1) Product Offered

13.3.3 Peptinov SAS Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Peptinov SAS Main Business Overview

13.3.5 Peptinov SAS Latest Developments

13.4 AbbVie Inc

13.4.1 AbbVie Inc Company Information

13.4.2 AbbVie Inc Interleukin 1 (IL1) Product Offered

13.4.3 AbbVie Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AbbVie Inc Main Business Overview

13.4.5 AbbVie Inc Latest Developments

13.5 Swedish Orphan Biovitrum AB

13.5.1 Swedish Orphan Biovitrum AB Company Information

13.5.2 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product Offered

13.5.3 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Swedish Orphan Biovitrum AB Main Business Overview

13.5.5 Swedish Orphan Biovitrum AB Latest Developments

13.6 TWi Biotechnology Inc

13.6.1 TWi Biotechnology Inc Company Information

13.6.2 TWi Biotechnology Inc Interleukin 1 (IL1) Product Offered

13.6.3 TWi Biotechnology Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 TWi Biotechnology Inc Main Business Overview

13.6.5 TWi Biotechnology Inc Latest Developments

13.7 XBiotech Inc

13.7.1 XBiotech Inc Company Information

13.7.2 XBiotech Inc Interleukin 1 (IL1) Product Offered

13.7.3 XBiotech Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 XBiotech Inc Main Business Overview

13.7.5 XBiotech Inc Latest Developments

13.8 Cell Medica Ltd

13.8.1 Cell Medica Ltd Company Information

13.8.2 Cell Medica Ltd Interleukin 1 (IL1) Product Offered

13.8.3 Cell Medica Ltd Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Cell Medica Ltd Main Business Overview

13.8.5 Cell Medica Ltd Latest Developments

13.9 Exicure Inc

13.9.1 Exicure Inc Company Information

13.9.2 Exicure Inc Interleukin 1 (IL1) Product Offered

13.9.3 Exicure Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Exicure Inc Main Business Overview

13.9.5 Exicure Inc Latest Developments

13.10 Immune Response BioPharma Inc

13.10.1 Immune Response BioPharma Inc Company Information

13.10.2 Immune Response BioPharma Inc Interleukin 1 (IL1) Product Offered

13.10.3 Immune Response BioPharma Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Immune Response BioPharma Inc Main Business Overview

13.10.5 Immune Response BioPharma Inc Latest Developments

13.11 Novartis AG

13.11.1 Novartis AG Company Information

13.11.2 Novartis AG Interleukin 1 (IL1) Product Offered

13.11.3 Novartis AG Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Novartis AG Main Business Overview

13.11.5 Novartis AG Latest Developments

13.12 Omnitura Therapeutics Inc

13.12.1 Omnitura Therapeutics Inc Company Information

13.12.2 Omnitura Therapeutics Inc Interleukin 1 (IL1) Product Offered

13.12.3 Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Omnitura Therapeutics Inc Main Business Overview

13.12.5 Omnitura Therapeutics Inc Latest Developments

13.13 Opsona Therapeutics Ltd

13.13.1 Opsona Therapeutics Ltd Company Information

13.13.2 Opsona Therapeutics Ltd Interleukin 1 (IL1) Product Offered

13.13.3 Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Opsona Therapeutics Ltd Main Business Overview

13.13.5 Opsona Therapeutics Ltd Latest Developments

13.14 Anacor Pharmaceuticals Inc

13.14.1 Anacor Pharmaceuticals Inc Company Information

13.14.2 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product Offered

13.14.3 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Anacor Pharmaceuticals Inc Main Business Overview

13.14.5 Anacor Pharmaceuticals Inc Latest Developments

13.15 Apexigen Inc

13.15.1 Apexigen Inc Company Information

13.15.2 Apexigen Inc Interleukin 1 (IL1) Product Offered

13.15.3 Apexigen Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Apexigen Inc Main Business Overview

13.15.5 Apexigen Inc Latest Developments

13.16 R Pharm

13.16.1 R Pharm Company Information

13.16.2 R Pharm Interleukin 1 (IL1) Product Offered

13.16.3 R Pharm Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 R Pharm Main Business Overview

13.16.5 R Pharm Latest Developments

13.17 Regeneron Pharmaceuticals Inc

13.17.1 Regeneron Pharmaceuticals Inc Company Information

13.17.2 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product Offered

13.17.3 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Regeneron Pharmaceuticals Inc Main Business Overview

13.17.5 Regeneron Pharmaceuticals Inc Latest Developments

14 Research Findings and Conclusion

Table 1. Interleukin 1 (IL1) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Interleukin 1 (IL1) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of APX-002

Table 4. Major Players of Canakinumab

Table 5. Major Players of Diacerein CR

Table 6. Major Players of IR-1000

Table 7. Major Players of Others

Table 8. Global Interleukin 1 (IL1) Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)

Table 10. Global Interleukin 1 (IL1) Revenue by Type (2017-2022) & ($ million)

Table 11. Global Interleukin 1 (IL1) Revenue Market Share by Type (2017-2022)

Table 12. Global Interleukin 1 (IL1) Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Interleukin 1 (IL1) Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)

Table 15. Global Interleukin 1 (IL1) Revenue by Application (2017-2022)

Table 16. Global Interleukin 1 (IL1) Revenue Market Share by Application (2017-2022)

Table 17. Global Interleukin 1 (IL1) Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Interleukin 1 (IL1) Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Interleukin 1 (IL1) Sales Market Share by Company (2020-2022)

Table 20. Global Interleukin 1 (IL1) Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Interleukin 1 (IL1) Revenue Market Share by Company (2020-2022)

Table 22. Global Interleukin 1 (IL1) Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Interleukin 1 (IL1) Producing Area Distribution and Sales Area

Table 24. Players Interleukin 1 (IL1) Products Offered

Table 25. Interleukin 1 (IL1) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Interleukin 1 (IL1) Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Interleukin 1 (IL1) Sales Market Share Geographic Region (2017-2022)

Table 30. Global Interleukin 1 (IL1) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Interleukin 1 (IL1) Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Interleukin 1 (IL1) Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Interleukin 1 (IL1) Sales Market Share by Country/Region (2017-2022)

Table 34. Global Interleukin 1 (IL1) Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Interleukin 1 (IL1) Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Interleukin 1 (IL1) Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Interleukin 1 (IL1) Sales Market Share by Country (2017-2022)

Table 38. Americas Interleukin 1 (IL1) Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Interleukin 1 (IL1) Revenue Market Share by Country (2017-2022)

Table 40. Americas Interleukin 1 (IL1) Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)

Table 42. Americas Interleukin 1 (IL1) Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)

Table 44. APAC Interleukin 1 (IL1) Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Interleukin 1 (IL1) Sales Market Share by Region (2017-2022)

Table 46. APAC Interleukin 1 (IL1) Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Interleukin 1 (IL1) Revenue Market Share by Region (2017-2022)

Table 48. APAC Interleukin 1 (IL1) Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)

Table 50. APAC Interleukin 1 (IL1) Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)

Table 52. Europe Interleukin 1 (IL1) Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Interleukin 1 (IL1) Sales Market Share by Country (2017-2022)

Table 54. Europe Interleukin 1 (IL1) Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Interleukin 1 (IL1) Revenue Market Share by Country (2017-2022)

Table 56. Europe Interleukin 1 (IL1) Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)

Table 58. Europe Interleukin 1 (IL1) Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Interleukin 1 (IL1) Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Interleukin 1 (IL1) Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Interleukin 1 (IL1) Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Interleukin 1 (IL1) Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Interleukin 1 (IL1) Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Interleukin 1 (IL1) Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Interleukin 1 (IL1) Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Interleukin 1 (IL1)

Table 69. Key Market Challenges & Risks of Interleukin 1 (IL1)

Table 70. Key Industry Trends of Interleukin 1 (IL1)

Table 71. Interleukin 1 (IL1) Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Interleukin 1 (IL1) Distributors List

Table 74. Interleukin 1 (IL1) Customer List

Table 75. Global Interleukin 1 (IL1) Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Interleukin 1 (IL1) Sales Market Forecast by Region

Table 77. Global Interleukin 1 (IL1) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Interleukin 1 (IL1) Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Interleukin 1 (IL1) Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Interleukin 1 (IL1) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Interleukin 1 (IL1) Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Interleukin 1 (IL1) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Interleukin 1 (IL1) Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Interleukin 1 (IL1) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Interleukin 1 (IL1) Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Interleukin 1 (IL1) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Interleukin 1 (IL1) Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Interleukin 1 (IL1) Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Interleukin 1 (IL1) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Interleukin 1 (IL1) Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Interleukin 1 (IL1) Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Interleukin 1 (IL1) Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Interleukin 1 (IL1) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Interleukin 1 (IL1) Revenue Market Share Forecast by Application (2023-2028)

Table 95. Optimum Therapeutics LLC Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 96. Optimum Therapeutics LLC Interleukin 1 (IL1) Product Offered

Table 97. Optimum Therapeutics LLC Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Optimum Therapeutics LLC Main Business

Table 99. Optimum Therapeutics LLC Latest Developments

Table 100. Orphit SAS Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 101. Orphit SAS Interleukin 1 (IL1) Product Offered

Table 102. Orphit SAS Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Orphit SAS Main Business

Table 104. Orphit SAS Latest Developments

Table 105. Peptinov SAS Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 106. Peptinov SAS Interleukin 1 (IL1) Product Offered

Table 107. Peptinov SAS Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Peptinov SAS Main Business

Table 109. Peptinov SAS Latest Developments

Table 110. AbbVie Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 111. AbbVie Inc Interleukin 1 (IL1) Product Offered

Table 112. AbbVie Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. AbbVie Inc Main Business

Table 114. AbbVie Inc Latest Developments

Table 115. Swedish Orphan Biovitrum AB Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 116. Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product Offered

Table 117. Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Swedish Orphan Biovitrum AB Main Business

Table 119. Swedish Orphan Biovitrum AB Latest Developments

Table 120. TWi Biotechnology Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 121. TWi Biotechnology Inc Interleukin 1 (IL1) Product Offered

Table 122. TWi Biotechnology Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. TWi Biotechnology Inc Main Business

Table 124. TWi Biotechnology Inc Latest Developments

Table 125. XBiotech Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 126. XBiotech Inc Interleukin 1 (IL1) Product Offered

Table 127. XBiotech Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. XBiotech Inc Main Business

Table 129. XBiotech Inc Latest Developments

Table 130. Cell Medica Ltd Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 131. Cell Medica Ltd Interleukin 1 (IL1) Product Offered

Table 132. Cell Medica Ltd Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Cell Medica Ltd Main Business

Table 134. Cell Medica Ltd Latest Developments

Table 135. Exicure Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 136. Exicure Inc Interleukin 1 (IL1) Product Offered

Table 137. Exicure Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Exicure Inc Main Business

Table 139. Exicure Inc Latest Developments

Table 140. Immune Response BioPharma Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 141. Immune Response BioPharma Inc Interleukin 1 (IL1) Product Offered

Table 142. Immune Response BioPharma Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Immune Response BioPharma Inc Main Business

Table 144. Immune Response BioPharma Inc Latest Developments

Table 145. Novartis AG Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 146. Novartis AG Interleukin 1 (IL1) Product Offered

Table 147. Novartis AG Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Novartis AG Main Business

Table 149. Novartis AG Latest Developments

Table 150. Omnitura Therapeutics Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 151. Omnitura Therapeutics Inc Interleukin 1 (IL1) Product Offered

Table 152. Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Omnitura Therapeutics Inc Main Business

Table 154. Omnitura Therapeutics Inc Latest Developments

Table 155. Opsona Therapeutics Ltd Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 156. Opsona Therapeutics Ltd Interleukin 1 (IL1) Product Offered

Table 157. Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. Opsona Therapeutics Ltd Main Business

Table 159. Opsona Therapeutics Ltd Latest Developments

Table 160. Anacor Pharmaceuticals Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 161. Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product Offered

Table 162. Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. Anacor Pharmaceuticals Inc Main Business

Table 164. Anacor Pharmaceuticals Inc Latest Developments

Table 165. Apexigen Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 166. Apexigen Inc Interleukin 1 (IL1) Product Offered

Table 167. Apexigen Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 168. Apexigen Inc Main Business

Table 169. Apexigen Inc Latest Developments

Table 170. R Pharm Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 171. R Pharm Interleukin 1 (IL1) Product Offered

Table 172. R Pharm Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 173. R Pharm Main Business

Table 174. R Pharm Latest Developments

Table 175. Regeneron Pharmaceuticals Inc Basic Information, Interleukin 1 (IL1) Manufacturing Base, Sales Area and Its Competitors

Table 176. Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product Offered

Table 177. Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 178. Regeneron Pharmaceuticals Inc Main Business

Table 179. Regeneron Pharmaceuticals Inc Latest Developments

List of Figures

Figure 1. Picture of Interleukin 1 (IL1)

Figure 2. Interleukin 1 (IL1) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Interleukin 1 (IL1) Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Interleukin 1 (IL1) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Interleukin 1 (IL1) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of APX-002

Figure 10. Product Picture of Canakinumab

Figure 11. Product Picture of Diacerein CR

Figure 12. Product Picture of IR-1000

Figure 13. Product Picture of Others

Figure 14. Global Interleukin 1 (IL1) Sales Market Share by Type in 2021

Figure 15. Global Interleukin 1 (IL1) Revenue Market Share by Type (2017-2022)

Figure 16. Interleukin 1 (IL1) Consumed in Esophageal Cancer

Figure 17. Global Interleukin 1 (IL1) Market: Esophageal Cancer (2017-2022) & (K Pcs)

Figure 18. Interleukin 1 (IL1) Consumed in Fallopian Tube Cancer

Figure 19. Global Interleukin 1 (IL1) Market: Fallopian Tube Cancer (2017-2022) & (K Pcs)

Figure 20. Interleukin 1 (IL1) Consumed in Bladder Cancer

Figure 21. Global Interleukin 1 (IL1) Market: Bladder Cancer (2017-2022) & (K Pcs)

Figure 22. Interleukin 1 (IL1) Consumed in Bechcer Disease

Figure 23. Global Interleukin 1 (IL1) Market: Bechcer Disease (2017-2022) & (K Pcs)

Figure 24. Interleukin 1 (IL1) Consumed in Others

Figure 25. Global Interleukin 1 (IL1) Market: Others (2017-2022) & (K Pcs)

Figure 26. Global Interleukin 1 (IL1) Sales Market Share by Application (2017-2022)

Figure 27. Global Interleukin 1 (IL1) Revenue Market Share by Application in 2021

Figure 28. Interleukin 1 (IL1) Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Interleukin 1 (IL1) Revenue Market Share by Company in 2021

Figure 30. Global Interleukin 1 (IL1) Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Interleukin 1 (IL1) Revenue Market Share by Geographic Region in 2021

Figure 32. Global Interleukin 1 (IL1) Sales Market Share by Region (2017-2022)

Figure 33. Global Interleukin 1 (IL1) Revenue Market Share by Country/Region in 2021

Figure 34. Americas Interleukin 1 (IL1) Sales 2017-2022 (K Pcs)

Figure 35. Americas Interleukin 1 (IL1) Revenue 2017-2022 ($ Millions)

Figure 36. APAC Interleukin 1 (IL1) Sales 2017-2022 (K Pcs)

Figure 37. APAC Interleukin 1 (IL1) Revenue 2017-2022 ($ Millions)

Figure 38. Europe Interleukin 1 (IL1) Sales 2017-2022 (K Pcs)

Figure 39. Europe Interleukin 1 (IL1) Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Interleukin 1 (IL1) Sales 2017-2022 (K Pcs)

Figure 41. Middle East & Africa Interleukin 1 (IL1) Revenue 2017-2022 ($ Millions)

Figure 42. Americas Interleukin 1 (IL1) Sales Market Share by Country in 2021

Figure 43. Americas Interleukin 1 (IL1) Revenue Market Share by Country in 2021

Figure 44. United States Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Interleukin 1 (IL1) Sales Market Share by Region in 2021

Figure 49. APAC Interleukin 1 (IL1) Revenue Market Share by Regions in 2021

Figure 50. China Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Interleukin 1 (IL1) Sales Market Share by Country in 2021

Figure 57. Europe Interleukin 1 (IL1) Revenue Market Share by Country in 2021

Figure 58. Germany Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Interleukin 1 (IL1) Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Interleukin 1 (IL1) Revenue Market Share by Country in 2021

Figure 65. Egypt Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Interleukin 1 (IL1) Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Interleukin 1 (IL1) in 2021

Figure 71. Manufacturing Process Analysis of Interleukin 1 (IL1)

Figure 72. Industry Chain Structure of Interleukin 1 (IL1)

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles